首页> 外文期刊>Folia histochemica et cytobiologica >Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators
【24h】

Comparative analysis of biological profiles of benign prostate hyperplasia and prostate cancer as potential diagnostic, prognostic and predictive indicators

机译:良性前列腺增生和前列腺癌生物学特征的比较分析作为潜在的诊断,预后和预测指标

获取原文
           

摘要

The prognosis in prostate cancer depends on several clinical-morphological factors, such as Gleason score, pTNM and preoperative PSA level. Reliable biological markers are being sought to supplement clinicalmorphological data in order to better predict prognosis and to select an individualized therapeutic option. The aim of this study was a comparative analysis of the expression of biological markers, such as Hif-1 α , bcl-2, p53, Ki-67, cyclin D1 and CD44 in BPH and prostate cancer, as well as examining their association with standard prognostic factors in prostate cancer. The immunohistochemical analysis was made on 82 formalin-fixed, paraffin- embedded tissue blocks: 43 prostate cancer specimens derived from patients who had undergone radical resection, and 39 prostate bioptates derived from patients with BPH. A positive correlation was demonstrated between Gleason score and the expression of both Hif-1 α (R = 0.32, p α as a hypoxia marker and Ki-67 as a proliferation marker, both correlated with Gleason score, may constitute important additional prognostic indicators in prostate cancer patients. ( Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 3, pp. 452–457 )
机译:前列腺癌的预后取决于几种临床形态因素,例如格里森评分,pTNM和术前PSA水平。正在寻求可靠的生物学标记物以补充临床形态学数据,以便更好地预测预后并选择个性化的治疗选择。这项研究的目的是比较分析BPH和前列腺癌中Hif-1α,bcl-2,p53,Ki-67,cyclin D1和CD44等生物学标志物的表达,并研究它们与癌症的关系。前列腺癌的标准预后因素。免疫组织化学分析是在82个福尔马林固定,石蜡包埋的组织块上进行的:43例前列腺癌标本来自接受根治性切除术的患者,39例前列腺活检标本来自BPH患者。格里森评分与Hif-1α的表达呈正相关(R = 0.32,pα为缺氧标志物,Ki-67为增殖标志物,均与格里森评分相关,可能构成重要的预后指标。前列腺癌患者(Folia Histochemica et Cytobiologica 2011;第49卷,第3期,第452-457页)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号